Publication: ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis.
| dc.contributor.author | Mastrangelo, Annalaura | |
| dc.contributor.author | Robles-Vera, Iñaki | |
| dc.contributor.author | Sancho, David | |
| dc.date.accessioned | 2026-03-20T10:33:34Z | |
| dc.date.available | 2026-03-20T10:33:34Z | |
| dc.date.issued | 2026-03-09 | |
| dc.description.peerreviewed | Sí | |
| dc.description.tableofcontents | Work in the D.S. laboratory is funded by the Centro Nacional de Investigaciones Cardiovasculares (CNIC); the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement ERC-2016-Consolidator Grant 725091; Ministerio de Ciencia, Innovación y Universidades PID2022-137712OB-I00, CPP2021-0083 10, CPP2022-009762 and CPP2024-011365 MICIU/AEI/10.13039/501100011033 Agencia Estatal de Investigación, Unión Europea NextGenerationEU/PRTR; Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); Scientific Foundation of the Spanish Association Against Cancer (AECC-PRYGN246642SANC); Worldwide Cancer Research WWCR-25-0080; European Union ERC-2023-PoC; a research agreement with Inmunotek Ltd; and la Caixa Foundation (LCF/PR/HR23/52430012 and LCF/PR/HR22/52420019). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICIU and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence funded by Ministerio de Ciencia, Innovación y Universidades (CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The PESA study is funded by the CNIC and Banco Santander. This study was partially funded by an intramural grant to Borja Ibáñez and D.S. | |
| dc.format.number | 10 | |
| dc.format.page | 1141-1143 | |
| dc.format.volume | 47 | |
| dc.identifier.citation | Eur Heart J. 2026 Mar 9;47(10):1141-1143 | |
| dc.identifier.journal | EUROPEAN HEART JOURNAL | |
| dc.identifier.pubmedID | 41528840 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/27340 | |
| dc.language.iso | eng | |
| dc.publisher | OXFORD UNIV PRESS | |
| dc.relation.isreferencedby | PubMed | |
| dc.relation.publisherversion | 10.1093/eurheartj/ehaf1122 | |
| dc.repisalud.institucion | CNIC | |
| dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Inmunobiología | |
| dc.rights.accessRights | open access | |
| dc.title | ERC-funded proof of concept grant: targeting imidazoline 1-receptor in atherosclerosis. | |
| dc.type | editorial | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ERC_funded proof of concept grant_Eur Heart J_2026.pdf
- Size:
- 171.72 KB
- Format:
- Adobe Portable Document Format


